Cargando…

MON-600 Hydroethanolic Extract of Lampaya Medicinalis Phil. (Verbenaceae) Decreases Intracellular Triglycerides and Proinflammatory Marker Expression in Fatty Acid-Exposed HepG2 Hepatocytes

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic chronic disease worldwide. NAFLD is characterized by an abnormal triglyceride (TG) accumulation (steatosis) in the liver, that may lead to hepatic inflammation (1). DGAT2 is a key enzyme that catalyzes the final step of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ormazabal, Paulina, Sanhueza, Sofía, Herrera, Karin, Cifuentes, Mariana, Varì, Rosaria, Scazzocchio, Beatrice, Masella, Roberta, Paredes, Adrián, Morales, Glauco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207588/
http://dx.doi.org/10.1210/jendso/bvaa046.1167
_version_ 1783530640369516544
author Ormazabal, Paulina
Sanhueza, Sofía
Herrera, Karin
Cifuentes, Mariana
Varì, Rosaria
Scazzocchio, Beatrice
Masella, Roberta
Paredes, Adrián
Morales, Glauco
author_facet Ormazabal, Paulina
Sanhueza, Sofía
Herrera, Karin
Cifuentes, Mariana
Varì, Rosaria
Scazzocchio, Beatrice
Masella, Roberta
Paredes, Adrián
Morales, Glauco
author_sort Ormazabal, Paulina
collection PubMed
description Background: Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic chronic disease worldwide. NAFLD is characterized by an abnormal triglyceride (TG) accumulation (steatosis) in the liver, that may lead to hepatic inflammation (1). DGAT2 is a key enzyme that catalyzes the final step of TG synthesis and whose expression is elevated in NAFLD (2). FABP4 is a transporter of intracellular lipids and its levels are related with inflammation, characterized by a high expression of proinflammatory cytokines such as TNF-α, IL-6 and IL-1β. Palmitic acid (PA, C16:0) and oleic acid (OA; C18:1) are two of the most abundant fatty acids that participate in the formation of TGs in hepatic cells in vivo and in vitro (3). Lampaya medicinalis Phil. (Verbenaceae) is a small bush that grows in the “Puna atacameña” in the North of Chile. The infusion from leaves and aerial parts of the plant has been used by local ethnic groups to treat and cure inflammatory diseases (4). The aim of this study was to assess in vitro the effect of the hydroalcoholic extract of Lampaya medicinalis (HEL) against OA/PA-induced steatosis and proinflammatory marker expression in HepG2 hepatocytes. Methods: HEL (0.01, 0.1, 1, 10 μg/mL) cytotoxicity potential (48 h) was evaluated by Trypan blue exclusion. Cells were exposed for 48 h to 1 mM OA/PA (2:1) in the presence or not of 0.01 or 10 μg/mL HEL. Intracellular TGs were assessed with Oil Red O staining and quantified with Nile Red reagent by fluorimetry. mRNA expression of DGAT2, TNF-α, IL-6 and IL-1β was evaluated by qRT-PCR. FABP4 content was assessed by Western blot. The levels of TNF-α and IL-6 in the culture media were analysed by ELISA. Results: HEL was not cytotoxic at any concentration assessed (n=4; p>0.05). The increased content of TG induced by OA/PA was reduced in the presence of HEL (n=7; p<0.05), showing a strong consistency with Oil Red O staining. The increase in the protein content of FABP4 as well as the increment in mRNA expression of DGAT2, TNF-α, IL-6 and IL-1β induced by OA/PA were lower in cells co-exposed to HEL (n=6-9; p<0.05). The incubation with HEL+OA/PA reduced proinflammatory cytokine levels in culture media compared to cells exposed to OA/PA alone (n=6-7; p<0.05). Conclusion: HEL reduces the OA/PA-induced increase in intracellular TG, DGAT2 and proinflammatory cytokine expression and FABP4 content, as well as the levels of secreted proinflammatory cytokines in HepG2 cells. These findings suggest a protective role for HEL against OA/PA-induced steatosis and inflammation, and therefore that Lampaya medicinalis may represent a promising therapeutic tool for pathologies such as NAFLD. References: (1) Gluchowski L, et al. Nat Rev Gastroenterol Hepatol. 2017;14(6):343-355. (2) Perry, et al. Nature. 2014;510(7503):84-91. (3) Cunningham P, et al. J Nutr. 2009;139(4):636–639. (4) Morales G, et al. Biol Res. 2014;47:6.
format Online
Article
Text
id pubmed-7207588
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72075882020-05-13 MON-600 Hydroethanolic Extract of Lampaya Medicinalis Phil. (Verbenaceae) Decreases Intracellular Triglycerides and Proinflammatory Marker Expression in Fatty Acid-Exposed HepG2 Hepatocytes Ormazabal, Paulina Sanhueza, Sofía Herrera, Karin Cifuentes, Mariana Varì, Rosaria Scazzocchio, Beatrice Masella, Roberta Paredes, Adrián Morales, Glauco J Endocr Soc Adipose Tissue, Appetite, and Obesity Background: Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic chronic disease worldwide. NAFLD is characterized by an abnormal triglyceride (TG) accumulation (steatosis) in the liver, that may lead to hepatic inflammation (1). DGAT2 is a key enzyme that catalyzes the final step of TG synthesis and whose expression is elevated in NAFLD (2). FABP4 is a transporter of intracellular lipids and its levels are related with inflammation, characterized by a high expression of proinflammatory cytokines such as TNF-α, IL-6 and IL-1β. Palmitic acid (PA, C16:0) and oleic acid (OA; C18:1) are two of the most abundant fatty acids that participate in the formation of TGs in hepatic cells in vivo and in vitro (3). Lampaya medicinalis Phil. (Verbenaceae) is a small bush that grows in the “Puna atacameña” in the North of Chile. The infusion from leaves and aerial parts of the plant has been used by local ethnic groups to treat and cure inflammatory diseases (4). The aim of this study was to assess in vitro the effect of the hydroalcoholic extract of Lampaya medicinalis (HEL) against OA/PA-induced steatosis and proinflammatory marker expression in HepG2 hepatocytes. Methods: HEL (0.01, 0.1, 1, 10 μg/mL) cytotoxicity potential (48 h) was evaluated by Trypan blue exclusion. Cells were exposed for 48 h to 1 mM OA/PA (2:1) in the presence or not of 0.01 or 10 μg/mL HEL. Intracellular TGs were assessed with Oil Red O staining and quantified with Nile Red reagent by fluorimetry. mRNA expression of DGAT2, TNF-α, IL-6 and IL-1β was evaluated by qRT-PCR. FABP4 content was assessed by Western blot. The levels of TNF-α and IL-6 in the culture media were analysed by ELISA. Results: HEL was not cytotoxic at any concentration assessed (n=4; p>0.05). The increased content of TG induced by OA/PA was reduced in the presence of HEL (n=7; p<0.05), showing a strong consistency with Oil Red O staining. The increase in the protein content of FABP4 as well as the increment in mRNA expression of DGAT2, TNF-α, IL-6 and IL-1β induced by OA/PA were lower in cells co-exposed to HEL (n=6-9; p<0.05). The incubation with HEL+OA/PA reduced proinflammatory cytokine levels in culture media compared to cells exposed to OA/PA alone (n=6-7; p<0.05). Conclusion: HEL reduces the OA/PA-induced increase in intracellular TG, DGAT2 and proinflammatory cytokine expression and FABP4 content, as well as the levels of secreted proinflammatory cytokines in HepG2 cells. These findings suggest a protective role for HEL against OA/PA-induced steatosis and inflammation, and therefore that Lampaya medicinalis may represent a promising therapeutic tool for pathologies such as NAFLD. References: (1) Gluchowski L, et al. Nat Rev Gastroenterol Hepatol. 2017;14(6):343-355. (2) Perry, et al. Nature. 2014;510(7503):84-91. (3) Cunningham P, et al. J Nutr. 2009;139(4):636–639. (4) Morales G, et al. Biol Res. 2014;47:6. Oxford University Press 2020-05-08 /pmc/articles/PMC7207588/ http://dx.doi.org/10.1210/jendso/bvaa046.1167 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Adipose Tissue, Appetite, and Obesity
Ormazabal, Paulina
Sanhueza, Sofía
Herrera, Karin
Cifuentes, Mariana
Varì, Rosaria
Scazzocchio, Beatrice
Masella, Roberta
Paredes, Adrián
Morales, Glauco
MON-600 Hydroethanolic Extract of Lampaya Medicinalis Phil. (Verbenaceae) Decreases Intracellular Triglycerides and Proinflammatory Marker Expression in Fatty Acid-Exposed HepG2 Hepatocytes
title MON-600 Hydroethanolic Extract of Lampaya Medicinalis Phil. (Verbenaceae) Decreases Intracellular Triglycerides and Proinflammatory Marker Expression in Fatty Acid-Exposed HepG2 Hepatocytes
title_full MON-600 Hydroethanolic Extract of Lampaya Medicinalis Phil. (Verbenaceae) Decreases Intracellular Triglycerides and Proinflammatory Marker Expression in Fatty Acid-Exposed HepG2 Hepatocytes
title_fullStr MON-600 Hydroethanolic Extract of Lampaya Medicinalis Phil. (Verbenaceae) Decreases Intracellular Triglycerides and Proinflammatory Marker Expression in Fatty Acid-Exposed HepG2 Hepatocytes
title_full_unstemmed MON-600 Hydroethanolic Extract of Lampaya Medicinalis Phil. (Verbenaceae) Decreases Intracellular Triglycerides and Proinflammatory Marker Expression in Fatty Acid-Exposed HepG2 Hepatocytes
title_short MON-600 Hydroethanolic Extract of Lampaya Medicinalis Phil. (Verbenaceae) Decreases Intracellular Triglycerides and Proinflammatory Marker Expression in Fatty Acid-Exposed HepG2 Hepatocytes
title_sort mon-600 hydroethanolic extract of lampaya medicinalis phil. (verbenaceae) decreases intracellular triglycerides and proinflammatory marker expression in fatty acid-exposed hepg2 hepatocytes
topic Adipose Tissue, Appetite, and Obesity
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207588/
http://dx.doi.org/10.1210/jendso/bvaa046.1167
work_keys_str_mv AT ormazabalpaulina mon600hydroethanolicextractoflampayamedicinalisphilverbenaceaedecreasesintracellulartriglyceridesandproinflammatorymarkerexpressioninfattyacidexposedhepg2hepatocytes
AT sanhuezasofia mon600hydroethanolicextractoflampayamedicinalisphilverbenaceaedecreasesintracellulartriglyceridesandproinflammatorymarkerexpressioninfattyacidexposedhepg2hepatocytes
AT herrerakarin mon600hydroethanolicextractoflampayamedicinalisphilverbenaceaedecreasesintracellulartriglyceridesandproinflammatorymarkerexpressioninfattyacidexposedhepg2hepatocytes
AT cifuentesmariana mon600hydroethanolicextractoflampayamedicinalisphilverbenaceaedecreasesintracellulartriglyceridesandproinflammatorymarkerexpressioninfattyacidexposedhepg2hepatocytes
AT varirosaria mon600hydroethanolicextractoflampayamedicinalisphilverbenaceaedecreasesintracellulartriglyceridesandproinflammatorymarkerexpressioninfattyacidexposedhepg2hepatocytes
AT scazzocchiobeatrice mon600hydroethanolicextractoflampayamedicinalisphilverbenaceaedecreasesintracellulartriglyceridesandproinflammatorymarkerexpressioninfattyacidexposedhepg2hepatocytes
AT masellaroberta mon600hydroethanolicextractoflampayamedicinalisphilverbenaceaedecreasesintracellulartriglyceridesandproinflammatorymarkerexpressioninfattyacidexposedhepg2hepatocytes
AT paredesadrian mon600hydroethanolicextractoflampayamedicinalisphilverbenaceaedecreasesintracellulartriglyceridesandproinflammatorymarkerexpressioninfattyacidexposedhepg2hepatocytes
AT moralesglauco mon600hydroethanolicextractoflampayamedicinalisphilverbenaceaedecreasesintracellulartriglyceridesandproinflammatorymarkerexpressioninfattyacidexposedhepg2hepatocytes